1. Formulation Development and Improved Stability of a Combination Measles and Rubella Live-Viral Vaccine Dried for Use in the NanopatchTM Microneedle Delivery System. Issue 8 (3rd August 2021) Authors: Wan, Ying; Gupta, Vineet; Bird, Christopher; Pullagurla, Swathi R.; Fahey, Paul; Forster, Angus; Volkin, David B.; Joshi, Sangeeta B. Journal: Human vaccines & immunotherapeutics Issue: Volume 17:Issue 8(2021) Page Start: 2501 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Opportunities and challenges for commercializing microarray patches for vaccination from a MAP developer's perspective. Issue 4 (30th November 2022) Authors: Forster, Angus; Junger, Michael Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 4(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety, acceptability and tolerability of uncoated and excipient-coated high density silicon micro-projection array patches in human subjects. Issue 48 (4th December 2017) Authors: Griffin, Paul; Elliott, Suzanne; Krauer, Kenia; Davies, Cristyn; Rachel Skinner, S.; Anderson, Christopher D.; Forster, Angus Journal: Vaccine Issue: Volume 35:Issue 48(2017)Part B Page Start: 6676 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Usability, acceptability, and feasibility of a High-Density Microarray Patch (HD-MAP) applicator as a delivery method for vaccination in clinical settings. Issue 4 (30th November 2022) Authors: Davies, Cristyn; Taba, Melody; Deng, Lucy; Karatas, Ceylan; Bag, Shopna; Ross, Charles; Forster, Angus; Booy, Robert; Skinner, S. Rachel Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 4(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗